IPID
OBJREF is the name of the structure of marshalled interfaces in COM and DCOM. Because COM interfaces can only be called directly from the context where they originated, when they are needed in another context they are marshalled in this structure, which is then passed to the destination context where it is unmarshalled to a proxy that takes care of the necessary communication, for example passing messages or network packets or marshalling other interfaces passed in calls.
Beyond's analysis on IPID
- — Deutsche Bank partners with IPID to integrate advanced payment decision intelligence into its global operations
- — Deutsche Bank and IPID enter strategic partnership to deploy payment decision intelligence globally
- — IPID secures $16 million Series A to expand its payment‑intelligence platform that helps institutions verify payees in real‑time payments
Recent news mentioning IPID
- — Die Deutsche Bank und IPID geben Pläne für eine strategische Partnerschaft zur Verbesserung der Zahlungsentscheidungsintelligenz bekannt
- — Deutsche Bank and IPID announce plans for strategic partnership to enhance payment decision intelligence
- — La Deutsche Bank et IPID annoncent leur intention de conclure un partenariat stratégique visant à améliorer l'analyse décisionnelle en matière de paiements
- — Deutsche Bank and IPID announce plans for strategic partnership to enhance payment decision intelligence
- — IPID haalt zestien miljoen dollar op nu directe betalingen een groeiende wereldwijde blinde vlek blootleggen.
- — IPID lève 16 millions de dollars alors que les paiements instantanés mettent en évidence un angle mort de plus en plus important à l'échelle mondiale
- — Evonik élargit ses capacités d'administration de médicaments à base de lipides grâce à une nouvelle installation de fabrication conforme aux BPF à Vancouver
- — Evonik baut Produktionskapazitäten für lipidbasierte Wirkstoffe in Vancouver aus
- — Evonik expands lipid-based drug delivery capabilities with new GMP manufacturing facility in Vancouver
- — Evonik expands lipid-based drug delivery capabilities with new GMP manufacturing facility in Vancouver